Navigation Links
Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device
Date:10/16/2008

First Synthetic Nanotechnology Implant Offers Promising Patient Solutions

MARQUETTE, Mich., Oct. 16 /PRNewswire/ -- Pioneer Surgical Technology, Inc., a leader in innovative medical devices, announced today the successful human implantation of its new biologic inter-body spacer. The nanOss(TM)- Cervical cage is machined from mechanically robust nano-crystalline hydroxyapatite (HA) and is designed to function as bone. The surgeries were performed at hospitals in Beijing and Suzhou, China, on patients indicated for standard cervical fusion surgery using the nanOss(TM)-Cervical implant, bone graft material, and anterior cervical plate.

Dr. Hansen Yuan, Professor of Orthopaedic and Neurological Surgery, State University of New York Upstate Medical University, Syracuse, NY performed the surgeries with Chinese surgeons and says, "The nanOss-Cervical cage was handled and implanted similarly to PEEK (poly-ether-ether-ketone) cages, and was used in conjunction with routine rigid fixation. The benefit of nanOss technology to the patient is it is a safe, natural substance and is biocompatible."

Pioneer's nanOss-Cervical cage is intended to facilitate spinal fusion procedures, by simultaneously maintaining decompression and serving as a graft containment device in conjunction with traditional rigid fixation.

Pioneer's CEO and Chairman of the Board, Dr. Matthew N. Songer says, "The hydroxyapatite nanOss-Cervical design is the frontier of the new generation of biologic implants that will replace the foreign materials that are currently used to reconstruct the spine."

In less than a year from acquiring the nanOss technology, Pioneer's development teams have created the nanOss-Cervical cage for fusion procedures. Strength properties of materials made of nanOss technology are twice as strong as PEEK cages yet, being biologic, behave as if it were bone.

About Pioneer Surgical Technology

Pioneer(R) Surgical Technology, Inc. is a dynamic medical device firm founded in 1992. Pioneer's focus on innovation has resulted in over 100 U.S. and Foreign patents with numerous patents pending." The company's comprehensive portfolio of CE or investigational motion preservation devices, vertebral spacers, cervical plating systems, and MIS and Mini-Open Rod systems include notable trade names such as NuBac(TM), BacJac(TM), Contact(TM), IJAK(R), Clarity(TM), SlimFuse(TM), and Quantum(R). Pioneer entered the orthobiologics market with two acquisitions in 2007. Encelle(TM), Inc., developed E-Matrix(TM) for tissue regeneration. Angstrom(TM) Medica, Inc. is the first company to obtain FDA approval for a nanotechnology device -- nanOss(TM) -- hydroxyapatite bone void filler. Pioneer's Orthopaedic, Spine, and Biologic divisions produce state of the art, cost-effective solutions for surgical procedures that have proven difficult or problematic for both surgeons and patients. Pioneer employs more than 260 people worldwide.


'/>"/>
SOURCE Pioneer Surgical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pioneer(R) Surgical Technology Announces Market Release of FortrOss(TM), a Next Generation Bone Void Filler
2. DuPont Obtains Biotechnology Endorsement for Pioneer(R) Brand Products
3. Pioneer(R) Surgical Technology, Inc. Announces the Market Launch of the SlimFuse(TM) Anterior Cervical Plate System
4. Pioneer(R) Brand Soybeans From DuPont Deliver Step-Change in Soybean Yields
5. Pioneer(R) Surgical Technology Announces First Human Implants of its NuNec(TM) Cervical Arthroplasty Device
6. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
7. CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure
8. Reliant Technologies Announces FDA 510(K) Clearance of New Handpieces for Skin Resurfacing and Surgical Applications
9. New Opportunities in X-Ray Based Surgical Navigation With Ziehm NaviPort 3D
10. Sound Surgical Technologies Welcomes Dr. Mark Schafer as New Chief Technology Officer and Vice President of Research & Development
11. Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... June 21, 2017 , ... ... North Carolina, and engages Timothy Reinhardt to manage the new site. , Tim ... Pfizer Inc, with his most recent role as the Director of Manufacturing and ...
(Date:6/22/2017)... ... June 22, 2017 , ... Ovation Fertility supports ... a disease, bringing new hope for prospective parents who are challenged with costs ... back the World Health Organization’s designation in hopes of changing the way health ...
(Date:6/22/2017)... , ... June 22, 2017 , ... The first human ... 20 years until the first data on cross-contamination of human cell lines with HeLa ... an increasing issue in cell culture labs and is associated with dramatic consequences for ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... board of directors has formed a Higher Education Entrepreneurship Advisory Committee to implement ... institution presidents and other high-ranking representatives from 35 higher education institutions across the ...
Breaking Biology Technology:
(Date:4/13/2017)... India , April 13, 2017 According to ... Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, ... MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 Billion ... Growth Rate (CAGR) of 17.3%. ... MarketsandMarkets ...
(Date:4/6/2017)... , April 6, 2017 Forecasts ... ANPR, Document Readers, by End-Use (Transportation & Logistics, Government ... Oil, Gas & Fossil Generation Facility, Nuclear Power), Industrial, ... Other) Are you looking for a definitive ... ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
Breaking Biology News(10 mins):